Fecal microbiota transplant with prebiotic nutrition for functional constipation
Official title: The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation:a Pilot Study
Run by Peking Union Medical College Hospital · NCT07387952 · Data updated 2026-11-12
This will try fecal microbiota transplantation combined with a prebiotic nutrition plan to see if it helps adults aged 18–70 with chronic functional constipation that hasn’t improved with diet or laxatives.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | July 30, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 4, 2026 |
| Trial ID | NCT07387952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–70 with Rome IV functional constipation for at least six months who have not responded to dietary measures and at least two laxatives or probiotic treatments.
✕Probably not a fit
People who are pregnant or breastfeeding, who meet criteria for IBS rather than functional constipation, or who have secondary causes of constipation or contraindications to FMT are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional trial at Peking Union Medical College Hospital will give adults with Rome IV functional constipation fecal microbiota transplantation (FMT) combined with a targeted prebiotic nutritional intervention using a co-localization strategy. Participants must be 18–70 years old, have symptoms for at least six months, and have failed standard dietary measures and at least two laxatives or probiotics. Investigators will monitor safety and clinical outcomes such as stool frequency and consistency, and will analyze changes in fecal microbiota composition and metabolomic profiles. Outcomes will be compared over follow-up visits to determine whether the combined intervention produces clinical improvement and acceptable safety.
Why it matters
Potential benefit: If successful, the combined FMT and prebiotic approach could increase bowel movements, improve stool consistency, and reduce reliance on laxatives without surgery.
How similar studies have gone: Prior research suggests probiotics, prebiotics, and FMT can help chronic constipation, but combining FMT with a co-localized nutritional prebiotic intervention is a novel, pilot approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 18 to 70. 2. Diagnostic criteria: Functional constipation (FC) in accordance with Rome IV criteria, which should meet the following conditions: * Symptom requirements: The following at least 2 items should occur in ≥25% of bowel movements: a. Straining during defecation; b. Hard stool (Bristol Stool Classification score 1-2); c. Feeling of incomplete evacuation; d. Rectal obstruction sensation; e. Need for finger assistance during defecation; f. Spontaneous bowel movements \<3 times per week. * It is rare to have loose stools without laxatives. * Exclusion of irritable bowel syndrome (IBS): IBS diagnosis criteria not meeting Rome IV. * Disease course requirements: Symptoms persist for at least 6 months and meet the above criteria within the last 3 months. 3. Traditional treatment methods (dietary intervention, at least two laxatives or probiotics) are ineffective. Exclusion Criteria: 1. Pregnancy or lactation. 2. Unable to take the intervention product or complete the examination as required. 3. Language expression disorder or mental illness. 4. Physical examination showed severe liver and kidney dysfunction. 5. Acute gastrointestinal disease within 4 weeks. 6. Constipation caused by surgery in the past 4 weeks. 7. History or abnormal examination: cancer, severe enteritis, intestinal obstruction, inflammatory bowel disease, hypothyroidism, mental illness, stroke, heart disease, cirrhosis, renal failure, hematopoietic system diseases, organic bowel disease suggested by colonoscopy or imaging. 8. Participation in other clinical trials within 3 months prior to enrollment. 9. Other health problems are not suitable for participation in the study.
Where it's running
-
Peking Union Medical College Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Pengguang Yan
- Email: pengchengf@mail.sdu.edu.cn
- Phone: +8618810309887
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sacral nerve stimulation for children with bowel motility problems
This project tests sacral neuromodulation in children aged 3–18 with gastrointestinal motility disorders to see if imaging-guided, personalized implantation improves symptoms.
-
Bowel Irrigation Techniques for Chronic Constipation and Faecal Incontinence
This study tests two transanal irrigation devices in adults with bowel control problems to see which helps more in real-world care.
-
Fecal transplant for chemotherapy and targeted-therapy gut side effects in advanced gastrointestinal cancer
This trial will try oral fecal microbiota transplants (FMT) to see if they reduce chemotherapy or targeted-therapy–related gut symptoms in adults with advanced gastrointestinal cancers.
-
Parents' views on physical activity for children aged 6-12 with functional constipation
Researchers will ask parents of children aged 6-12 with functional constipation about their child's physical activity to see if supporting exercise could help symptoms and care.
-
Diet-driven approach to ease constipation in people with Parkinson’s
A dietitian-guided nutritional plan is tested to see if it increases weekly bowel movements and improves gut health in adults with Parkinson’s disease and functional constipation.
-
Psyllium versus fructooligosaccharide for improving bowel transit in women with functional constipation
This will test whether taking 20 g daily of psyllium or fructooligosaccharide for six days helps improve bowel movements and intestinal transit in adult women with functional constipation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.